Tumour rejection in immunized guinea-pigs.

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• The study investigates the morphological aspects of the antineoplastic defense mechanism.
• Hepatoma cells (line 2) in Sewall-Wright strain 13 guinea pigs typically lead to rapid tumor growth and host death within 8 weeks when injected intraperitoneally (i.p.).

Purpose of the Study:

• To examine the host's immune response to tumor challenge after pre-immunization.
• To identify the cellular players involved in the antineoplastic defense mechanism.

Main Methods:

• Intradermal injection of line 2 hepatoma cells 3 weeks prior to i.p. tumor cell challenge in strain 13 guinea pigs.
• Sequential histological analysis of tumor modules in pre-immunized animals.

Main Results:

• Intradermal injection of hepatoma cells conferred immunity, enabling hosts to reject tumors after initial growth.
• This protective effect demonstrated immunological specificity, as allogeneic hepatoma cells did not provide protection.
• Histological analysis revealed lymphocytes at early stages of tumor cell damage, followed by inflammatory cells like macrophages during tumor necrosis.

Conclusions:

• Pre-immunization with intradermal tumor cells effectively primes an antineoplastic defense mechanism.
• Lymphocytes appear to be the primary effectors of tumor cell damage, with macrophages involved in the response to necrosis.
• The study highlights the role of specific immune cells in mediating tumor rejection.